Results for tag: "Peritoneal Carcinomatosis Drug"

Peritoneal carcinomatosis is a rare form of cancer that affects the peritoneum, a thin layer of tissue that lines the abdominal cavity and covers most of the organs in the abdomen. It is most commonly caused by metastatic spread of other cancers, such as ovarian cancer, colorectal cancer, and gastric cancer. Treatment for peritoneal carcinomatosis typically involves a combination of chemotherapy, radiation therapy, and surgery. The peritoneal carcinomatosis drug market is a subset of the larger oncology drug market. It is composed of drugs used to treat peritoneal carcinomatosis, including chemotherapy drugs, targeted therapies, and immunotherapies. These drugs are used to reduce tumor size, reduce symptoms, and improve overall survival. Some companies in the peritoneal carcinomatosis drug market include Bristol-Myers Squibb, Merck, Pfizer, AstraZeneca, and Eli Lilly. Show Less Read more